Correlation between HHV-6 reactivation and multiple sclerosis disease activity

Journal of Medical Virology

Volumn 69, Issue 1, 2003, Pages 111-117

  Chapenko, Svetlana ^a   Millers, Andrejs ^b   Nora, Zaiga ^a   Logina, Inara ^b   Kukaine, Rita ^a   Murovska, Modra ^a  

^a UNIVERSITY OF LATVIA   (Latvia)

^b RIGA STRADINS UNIVERSITY   (Latvia)

Author keywords

IL 12; Latent infection; MRI; mRNA transcription; Serum plasma antibodies; Viremia

Indexed keywords

INTERLEUKIN 12; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; LATENT PERIOD; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; RISK ASSESSMENT; VIREMIA; VIRUS GENE; VIRUS REACTIVATION;

CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEUKOCYTES, MONONUCLEAR; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 6;

EID: 0037211715     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10258     Document Type: Article

References (44)

1. Ablashi DV, Agut H, Berneman Z, Campadelly-Fiume G, Carrigan D, Ceccerini-Nelli L, Chandran B, Chou S, Collandre H, Cone R, Dambaugh, T, Dewhurst S, DiLuca D, Foa-Tomasi L, Fleckenstein B, Frenkel N, Gallo R, Gompels U, Hall C, Jones M, Lawrence G, Martin M, Montagnier L, Neipel F, Nicholas J, Pellet P, Razzaque A, Torrelli F, Thomson B, Salahuddin S, Wyatt L, Yamanishi K. 1993. Human herpesvirus-6 strain groups: A nomenclature. Arch Virol 129:363-366.
2. Ablashi DV, Lapps W, Kaplan M, Whitman JE, Richert JR, Pearson GR. 1998. Human herpesvirus-6 (HHV-6) infection in multiple sclerosis: A preliminary report. Mult Scler 4:490-496.
3. Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB, Peterson DL, Pearson GR, Whitman JE. 2000. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CSF) patients. J Clin Virol 16:179-191.
4. Akhyani N, Berti R, Brennan MB, Soldan SS, Eaton JM, McFarland HF, Jacobson S. 2000. Tissue distribution and variant characterization of human herpesvirus (HHV)-6: Increased prevalence of HHV-6A in patients with multiple sclerosis. J Infect Dis 182:1321-1325.
5. Albright AV, Lavi E, Black JB, Goldberg S, O'Connor MJ, Gonzales-Scarano F. 1998. The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: Oligodendrocytes and microglia. J Neurovirol 4:486-494.
6. Alvarez-Lafuente R, Martin-Estefania C, de Las Heras V, Castrillo C, Cour I, Picazo JJ, Varela De Seijas E, Arroyo R. 2002. Prevalence of herpesvirus DNA in MS patients and healthy blood donors. Acta Neurol Scand 105:95-99.
7. Arena A, Liberto MC, Iannello D, Capozza AB, Foca A. 1999. Altered cytokine production after human herpesvirus type 6 infection. New Microbiol 22:293-300.
8. Balashov KE, Smith DR, Khoury SJ, Hafler DA, Weiner HL. 1997. Increased interleukin-12 production in progressive multiple sclerosis: Induction by activated CD4+ T cells via CD40 ligand. Proc Natl Acad Sci USA 94:599-603.
9. Bandobashi K, Daibata M, Kamioka M, Tanaka Y, Kubonishi I, Taguchi H, Ohtsuki Y, Miyoshi I. 1997. Human herpesvirus 6 (HHV-6)-positive Burkitt's lymphoma: Establishment of a novel cell line infected with HHV-6. Blood 90:1200-1207.
10. Campadelli-Fiume G, Mirandola P, Menotti L. 1999. Human herpesvirus 6: An emerging pathogen. Emerg Infect Dis 5:353-366.
11. Carrieri PB, Maiorino A, Provitera V, Soccia E, Perrella O. 1992. Cytokines in the pathogenesis of multiple sclerosis. Acta Neurol (Napoli) 14:334-341.
12. Cermelli C, Jacobson S. 2000. Viruses and multiple sclerosis. Viral Immunol 13:255-257.
13. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, Schad PA, Stewart PM, Nowinski RC, Brown JP, Burmer GC. 1995. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 92:7440-7444.
14. Chan PK, Ng HK, Cheng AF. 1999. Detection of human herpesvirus 6 and 7 genomic sequences in brain tumors. J Clin Pathol 52:620-623.
15. Christensen T, Dissing Sorensen P, Riemann H, Hansen HJ, Munch M, Haahr S, Moller-Larsen A. 2000. Molecular characterization of HERV-H variants associated with multiple sclerosis. Acta Neurol Scand 101:229-238.
16. Comabella M, Balashov K, Issazadeh S, Smith D, Weiner HL, Khoury SJ. 1998. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophamide therapy. J Clin Invest 102:671-678.
17. Drulovic J, Mostarica-Stojkovic M, Levic Z, Mesaros S, Stojsavljevic N, Popadic D, Pravica V. 1998. Serum interleukin-12 levels in patients with multiple sclerosis. Neurosci Lett 251:129-132.
18. Filippi M. 1998. The role of new magnetic resonance imaging techniques in the evaluation of multiple sclerosis. Int MS Journal 84:89-102.
19. Friedman JE, Lyons MJ, Cu G. 1999. The association of the human herpesvirus 6 and MS. Mult Scler 5:355-362.
20. Hay KA, Tenser RB. 2000. Leukotropic herpesviruses in multiple sclerosis. Mult Scler 6:66-68.
21. He J, McCarthy M, Zhou Y, Chandran B, Wood C. 1996. Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol 70:1296-1300.
22. Heesen C, Sieverding F, Schoser BG, Hadji B, Kunze K. 1999. Interleukin-12 is detectable in sera of patients with multiple sclerosis: Association with chronic progressive disease course? Eur J Neurol 6:591-596.
23. Knox KK, Brewer JH, Henry JM, Harrington DJ, Carrigan DR. 2000. Human herpesvirus 6 and multiple sclerosis: Systemic active infections in patients with early disease. Clin Infect Dis 31:894-903.
24. Levy J. 1997. Three new human herpesviruses types 6, 7, and 8. Lancet 349:558-562.
25. Martino G, Hartung HP. 1999. Immunopathogenesis of multiple sclerosis: The role of T cells. Curr Opin Neurol 12:309-321.
26. Matusevicius D, Kivisakk P, Navikas V, Soderstrom M, Fredrikson S, Link H. 1998. Interleukin-12 and perforin mRNA expression is augmented in blood mononuclear cells in multiple sclerosis. Scand J Immunol 47:582-590.
27. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. 1991. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: Concerted action guidelines. J Neurol Neurosurg Psychiatry 54:683-688.
28. Nicoletti F, Patti F, Cocuzza C, Patti F, Cocuzza C, Zaccone P, Nicoletti A, Di Marco R, Reggio A. 1996. Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. J Neuroimmunol 70:87-90.
29. Noppen C, Luescher U, Zuber M, Spagnoli GC, Schaefer C. 1997. Detection of tumor-associated antigen gene expression in peripheral blood by RT-PCR in combination with the mRNA isolation kit for blood/bone marrow. Biochemica 4:11-13.
30. Norton RA, Caserta MT, Hall CB, Schnabel K, Hocknell P, Dewhurst S. 1999. Detection of human herpesvirus 6 by reverse transcription-PCR. JCM 37:3672-3675.
31. Ongradi J, Rajda C, Marodi CL, Csiszar A, Vecsei L. 1999. A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients. J Neurovirol 5:529-532.
32. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, Mandrand B, Collaborative Research Group on Multiple Sclerosis. 1997. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The collaborative research group on multiple sclerosis. Proc Natl Acad Sci USA 94:7583-7588.
33. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. 1983. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 13:227-231.
34. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B, Gallo RC. 1986. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596-601.
35. Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL, Gallo RC, Lusso P. 1995. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 171:273-280.
36. Soldan S, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Moloni HW, McFarland HF, Lin HC, Patnaik M, Jacobson S. 1997. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM responses to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 3:1394-1397.
37. Taus C, Pucci E, Cartechini E, Fie A, Giuliani G, Clementi M, Menzo S. 2000. Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. Acta Neurol Scand 101:224-228.
38. Tomsone V, Logina I, Millers A, Chapenko S, Kozireva S, Murovska M. 2001. Association of human herpesvirus 6 and human herpesvirus 7 with demyelinating diseases of the nervous system. J Neurovirol 7:564-569.
39. Trinchieri G. 1994. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory function in the generation of T-helper cell type and cytotoxic lymphocytes. Blood 84:4008-4027.
40. van Boxel-Desaire AH, Hoff SC, van Oosten BW, Verweij CL, Drager AM, Ader HJ, van Houwelingen JC, Barkhof F, Polman CH, Nagelkerken L. 1999. Decreased interleukin-10 and increased interleukin-12 p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann Neurol 46:695-703.
41. Vandamme A-M, Fransen K, Debaisieux I, Marissens D, Sprecher S, Vaira D, Vanderbroucke AT, Verhofstede C. 1995. Standardization of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harboring strains of diverse geographical origin. The Belgian AIDS Reference Laboratories. J Virol Methods 51:305-316.
42. Weiner ML, Guttmann CR, Khoury SJ, Orav EJ, Hohol MJ, Kikinis R, Jolesz FA. 2000. Serial magnetic resonance imaging in multiple sclerosis: Correlation with attacks, disability, and disease stage. J Neuroimmunol 104:164-173.
43. Yoshikawa T, Ihara M, Suzuki K, Suga S, Matsubara T, Furukawa S, Asano Y. 2000. Invasion by human herpesvirus 6 and human herpesvirus 7 of the central nervous system in patients with neurological signs and symptoms. Arch Dis Child 83:170-171.
44. Zhang S, Kaplan MH. 2000. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-gamma expression. J Immunol 165:1374-1380.